MARKET

PAVM

PAVM

PAVmed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.730
+0.010
+0.27%
After Hours: 3.790 +0.06 +1.61% 19:56 03/05 EST
OPEN
3.800
PREV CLOSE
3.720
HIGH
3.820
LOW
3.080
VOLUME
10.35M
TURNOVER
--
52 WEEK HIGH
5.63
52 WEEK LOW
1.300
MARKET CAP
304.69M
P/E (TTM)
-4.8707
1D
5D
1M
3M
1Y
5Y
BRIEF-Pavmed Retires Convertible Debt
reuters.com · 4d ago
PAVmed Retires Convertible Debt
NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has retired all of the Company’s outstandin...
GlobeNewswire · 4d ago
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
NEW YORK, March 01, Mar 01, 2021 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company"...
GlobeNewswire · 6d ago
PAVmed closes $45M capital raise
PAVmed ([[PAVM]] -6.2%)  announces the closing of its previously announced underwritten public offering of about 9.8M shares of with gross proceeds of about $45M.PAVmed intends to use the net proceeds from
Seekingalpha · 02/25 17:44
PAVmed Announces Closing of its Public Offering of Common Stock
NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced underwritten...
GlobeNewswire · 02/25 17:37
Top Penny Stocks To Watch Today If Tech Is Your Focus
Penny Stocks · 02/24 21:12
3 Penny Stocks To Watch Before Next Week
Feb 24, 2021 (Penny Stocks via COMTEX) -- Are These On Your Penny Stocks List? With so much momentum every day for penny stocks, traders are always looking...
Penny Stocks · 02/24 21:11
Vascular Biogenics, Sunesis Pharmaceuticals leads healthcare gainers; Isoray, Vaccine among major losers
Gainers: Vascular Biogenics (VBLT) +22%, Sunesis Pharmaceuticals (SNSS) +21%, Savara (SVRA) +8%, Pandion Therapeutics (PAND) +5%.Losers: PAVmed PAVM -17%, Isoray (ISR) -16%, Vaccinex (VCNX) -16%, Onconova Therapeutics ONTX -15%, electroCore (ECOR) -14%.
Seekingalpha · 02/23 16:03
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PAVM. Analyze the recent business situations of PAVmed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PAVM stock price target is 7.42 with a high estimate of 9.00 and a low estimate of 5.25.
EPS
Institutional Holdings
Institutions: 84
Institutional Holdings: 9.00M
% Owned: 11.02%
Shares Outstanding: 81.69M
TypeInstitutionsShares
Increased
21
1.62M
New
24
617.92K
Decreased
11
218.95K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.35%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/Chief Executive Officer/Director
Lishan Aklog
President/Chief Financial Officer/Secretary
Dennis McGrath
President/Chief Financial Officer/Secretary
Dennis Mcgrath
Vice Chairman/Independent Director
Michael Glennon
Other
Brian DeGuzman
Independent Director
David Battleman
Independent Director
James Cox
Independent Director
Ronald Sparks
Independent Director
David Weild
No Data
About PAVM
PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does not have an indwelling intravascular component. CarpX is a percutaneous device to treat carpal tunnel syndrome. NextCath is a self-anchoring catheter, which does not require suturing, traditional anchoring techniques or add-on catheter securement devices. The Company's DisappEAR is an Antibiotic-eluting Resorbable Ear Tubes. The Company is engaged in developing and commercializing antibiotic-eluting resorbable ear tubes based on an aqueous silk technology conceived and developed at these institutions. The Company is engaged in developing disposable infusion system with variable flow resistors. Caldus is a disposable tissue ablation device.

Webull offers kinds of PAVmed Inc stock information, including NASDAQ:PAVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAVM stock methods without spending real money on the virtual paper trading platform.